Internal medicine physicians are already trained to care for complex medical conditions, and HIV is no different, especially as adults age and develop diabetes, heart disease, and other conditions.
1 Nov 2023
While the long-acting injectable form of cabotegravir has shown superior effectiveness for HIV pre-exposure prophylaxis (PrEP), a cost-effectiveness analysis found that the drug is too expensive at its current price compared to the daily oral medication available as a generic.
1 Feb 2022
A 35-year-old man undergoes follow-up evaluation for a positive HIV screening test obtained 3 days ago. He is ready to start treatment. HIV testing 1 year ago was negative. He takes no medications. The physical examination is normal. Following immunoassays, what is the most appropriate treatment?
12 Jul 2022
Antiretroviral therapy has made an impact in treating HIV, but preexposure prophylaxis has created a huge opportunity in preventing infection, with internists poised to play a role.
1 Mar 2020
The recommendations from the HIV Medicine Association of the Infectious Diseases Society of America update a 2013 guideline on this topic and reflect the changing primary care needs of people with HIV who have longer lifespans due to improved treatment.
17 Nov 2020
A 31-year-old man arrives to establish care for newly diagnosed HIV infection. He is asymptomatic. Medical history is otherwise noncontributory, and he takes no medications. Following a physical exam and review of lab studies, what is the most appropriate next step in management?
17 Aug 2021
This column reviews recent recalls, alerts, and approvals.
1 Feb 2023
The recommendations from the International Antiviral Society-USA cover initiation of antiretroviral therapy (ART), switching regimens, ART in older patients with HIV, and HIV and COVID-19, among other topics.
6 Dec 2022
This issue announces an upcoming new name for the publication, as well as stories on HIV as a chronic disease and on treating the flu.
1 Nov 2023
One study found that switching from tenofovir disoproxil fumarate to tenofovir alafenamide was associated with obesity and dyslipidemia, while another suggested that deferred antiretroviral therapy (ART) initiation was associated with a small increase in risk for AIDS-defining cancer.
16 Mar 2021